Fertility and Sterility
Volume 88, Issue 2 , Pages 390-395 , August 2007

Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR

  • Stacea Bowen, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology and Women’s Health, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • John Norian, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology and Women’s Health, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • Nanette Santoro, M.D.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • Lubna Pal, M.B., B.S., M.S.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine, Bronx, New York
    • Corresponding Author InformationReprint requests: Lubna Pal, M.B., B.S., M.S., Department of Obstetrics, Gynecology, and Women’s Health, Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine and Montefiore Medical Center, Mazer 316, 1300 Morris Park Avenue, Bronx, New York 10461 (FAX: 718-430-8586).

Received 13 August 2006 ,Revised 27 November 2006 ,Accepted 27 November 2006.

References 

  1. Menken J, Trussell J, Larsen U. Age and infertility. Science. 1986;233:1389–1394
  2. Speroff L. The effect of aging on fertility. Curr Opin Obstet Gynecol. 1994;6:115–120
  3. Buyalos RP, Daneshmand S, Brzechffa PR. Basal estradiol and follicle stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy. Fertil Steril. 1997;68:272–277
  4. Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod. 2000;15:2341–2346
  5. Galey-Fontaine J, Cedrin-Durnerin I, Chaibi R, Massin N, Hugues JN. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online. 2005;10:94–99
  6. de Boer EJ, den Tonkelaar L, te Velde ER, Burger CW, Klip H, van Leeuwen FE, et al. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril. 2002;77:978–985
  7. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, van Leevwen FE OMEGA-project group. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod. 2003;18:1544–1552
  8. Lawson R, El-Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, et al. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod. 2003;18:527–533
  9. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651–654
  10. Toner JP, Philput CB, Jones GS, Mausher SJ. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991;55:784–791
  11. Frattarelli JL, Lauria-Costa DF, Miller BT, Bergh PA, Scott RT. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril. 2000;74:512–517
  12. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468–471
  13. Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod. 1999;14:409–415
  14. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker of ovarian aging. Fertil Steril. 2002;77:357–362
  15. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–3071
  16. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti mullerian hormone is more strongly related to ovarian follicular status than serum inhibin, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18:323–327
  17. Tremellen KP, Kolo M, Gilmore A, LeKanage DN. Anti-mullerian hormone as a marker of ovarian reserve. Aust NZ J Obstet Gynaecol. 2005;45:20–24
  18. Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld L. An elevated day three follicle stimulating hormone: luteinizing hormone ratio (FSH: LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril. 1996;65:588–593
  19. Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict “low responders”. Fertil Steril. 2005;83:883–888
  20. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in-vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002;77:328–336
  21. Lass A, Skull J, McVeigh E, Margara R, Winston RM. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotropin for in vitro fertilization can predict poor response. Hum Reprod. 1997;12:294–297
  22. Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotropins in in vitro fertilization. Hum Reprod. 1997;12:220–223
  23. Syrop CH, Dawson JD, Husman KJ, Sparks AF, van Voorhis J. Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod. 1999;14:1752–1756
  24. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of clomiphene citrate challenge test. Fertil Steril. 1990;53:295–301
  25. Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol. 1993;82:539–544
  26. Navot D, Rosenwaks Z, Margolith E. Prognostic assessment of female fecundity. Lancet. 1987;2:645–647
  27. Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‘poor responders’ in in-vitro fertilization. Hum Reprod. 1994;9:1607–1611
  28. Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ. The gonadotropin releasing hormone agonist stimulation test—a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril. 1991;56:711–717
  29. Guleki B, BuIbul Y, Onvural A, Yorukoglu K, Posaci C, Demir N, et al. Accuracy of ovarian reserve tests. Hum Reprod. 1999;14:2822–2826
  30. Kwee J, Schats R, McDonnell J, Lambalk CB, Schoemaker J. Intercycle variability of OR tests: results of a prospective randomized study. Hum Reprod. 2004;19:590–595
  31. Abdalla H, Thum MY. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH. Hum Reprod. 2006;21:171–174
  32. Frattarelli JL, Levi AJ, Miller BT. A prospective novel method of determining ovarian size during in vitro fertilization cycles. J Assist Reprod Genet. 2002;19:39–41
  33. Sharara FI, Beatse SN, Leonardi MR, Navot D, Scott RT. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test. Fertil Steril. 1994;62:257–262
  34. Van Voorhis BJ, Dawson JD, Stovall DW, Sparks AE, Syrop CH. The effects of smoking on ovarian function and fertility during assisted reproduction cycles. Obstet Gynecol. 1996;88:785–791
  35. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47
  36. Jonard S, Robert Y, Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod. 2005;20:2893–2898
  37. Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definition. Hum Reprod Update. 2003;9:505–514
  38. Harlass FE, Plymate SR, Fariss BL, Belts RP. Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril. 1984;42:649–652
  39. Reid R, Van Vugt DA. Weight related changes in reproductive function. Fertil Steril. 1987;48:905–911
  40. Spandorfer SD, Kump L, Goldschlag D, Brodkin T, Davis OK. Obesity and in vitro fertilization; negative influences and outcome. J Reprod Med. 2004;49:973–977
  41. Higgins RV, van Nagell JR, Woods CH, Thompson EA, Kryscio RJ. Interobserver variation in ovarian measurements using transvaginal sonography. Gynecol Oncol. 1990;39:69–71

 Supported in part by National Institutes of Health (Bethesda, Maryland) grants 5K12 RR17672 (L.P.) and CD 41978 (N.S.).

PII: S0015-0282(06)04711-X

doi: 10.1016/j.fertnstert.2006.11.175

Fertility and Sterility
Volume 88, Issue 2 , Pages 390-395 , August 2007

Article Tools

* Image Usage & Resolution